secwatch.observer — SEC 8-K summary
======================================

Issuer:     KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)
CIK:        0000055529
Form:       8-K
Filed at:   2024-12-11T23:59:59+00:00
Accession:  0000055529-24-000037
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kewaunee Scientific Q2 FY2025: Sales down 5.3%, diluted EPS $1.01 vs $0.93 YoY; backlog record $184.4M
--------------------------------------------------------------------------------

- Net sales $47.8M (down 5.3% YoY); domestic sales up 6.5%, international down 30.1% due to India construction delays.
- Diluted EPS $1.01 vs $0.93 YoY; net earnings $3.0M vs $2.7M; EBITDA $4.9M.
- Record backlog $184.4M (Oct 31, 2024) vs $146.3M a year ago and $155.6M at April 30, 2024.
- Domestic segment net earnings $4.5M (up from $3.1M); international net earnings $0.4M (down from $0.5M).
- Incurred $2.3M in acquisition-related expenses for Nu Aire (closed Nov 1, 2024); adjusted diluted EPS would be $1.41.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/55529/000005552924000037/0000055529-24-000037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/55529/000005552924000037/kequ-20241211.htm
  HTML page:      https://secwatch.observer/filing/0000055529-24-000037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer